TY - JOUR
T1 - Improvement of advanced Parkinson’s disease manifestations with deep brain stimulation of the subthalamic nucleus
T2 - A single institution experience
AU - Rabie, Ahmed
AU - Metman, Leo Verhagen
AU - Fakhry, Mazen
AU - Eassa, Ayman Youssef Ezeldin
AU - Fouad, Wael
AU - Shakal, Ahmed
AU - Slavin, Konstantin V.
N1 - Publisher Copyright:
© 2016 by the authors; licensee MDPI, Basel, Switzerland.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - We present our experience at the University of Illinois at Chicago (UIC) in deep brain stimulation (DBS) of the subthalamic nucleus (STN), describing our surgical technique, and reporting our clinical results, and morbidities. Twenty patients with advanced Parkinson’s disease (PD) who underwent bilateral STN-DBS were studied. Patients were assessed preoperatively and followed up for one year using the Unified Parkinson’s Disease Rating Scale (UPDRS) in “on” and “off” medication and “on” and “off” stimulation conditions. At one-year follow-up, we calculated significant improvement in all the motor aspects of PD (UPDRS III) and in activities of daily living (UPDRS II) in the “off” medication state. The “off” medication UPDRS improved by 49.3%, tremors improved by 81.6%, rigidity improved by 50.0%, and bradykinesia improved by 39.3%. The “off” medication UPDRS II scores improved by 73.8%. The Levodopa equivalent daily dose was reduced by 54.1%. The UPDRS IVa score (dyskinesia) was reduced by 65.1%. The UPDRS IVb score (motor fluctuation) was reduced by 48.6%. Deep brain stimulation of the STN improves the cardinal motor manifestations of the idiopathic PD. It also improves activities of daily living, and reduces medication-induced complications.
AB - We present our experience at the University of Illinois at Chicago (UIC) in deep brain stimulation (DBS) of the subthalamic nucleus (STN), describing our surgical technique, and reporting our clinical results, and morbidities. Twenty patients with advanced Parkinson’s disease (PD) who underwent bilateral STN-DBS were studied. Patients were assessed preoperatively and followed up for one year using the Unified Parkinson’s Disease Rating Scale (UPDRS) in “on” and “off” medication and “on” and “off” stimulation conditions. At one-year follow-up, we calculated significant improvement in all the motor aspects of PD (UPDRS III) and in activities of daily living (UPDRS II) in the “off” medication state. The “off” medication UPDRS improved by 49.3%, tremors improved by 81.6%, rigidity improved by 50.0%, and bradykinesia improved by 39.3%. The “off” medication UPDRS II scores improved by 73.8%. The Levodopa equivalent daily dose was reduced by 54.1%. The UPDRS IVa score (dyskinesia) was reduced by 65.1%. The UPDRS IVb score (motor fluctuation) was reduced by 48.6%. Deep brain stimulation of the STN improves the cardinal motor manifestations of the idiopathic PD. It also improves activities of daily living, and reduces medication-induced complications.
KW - Clinical outcome
KW - Deep brain stimulation
KW - Neuromodulation
KW - Parkinson’s disease
KW - Subthalamic nucleus
UR - http://www.scopus.com/inward/record.url?scp=85007109707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007109707&partnerID=8YFLogxK
U2 - 10.3390/brainsci6040058
DO - 10.3390/brainsci6040058
M3 - Article
C2 - 27983589
AN - SCOPUS:85007109707
SN - 2076-3425
VL - 6
JO - Brain Sciences
JF - Brain Sciences
IS - 4
M1 - 58
ER -